Educational information, not medical advice — ask your doctor or midwife.
Huamanpinta is a spiny Andean shrub, Chuquiraga spinosa. Highland healers in Peru dried the stems and leaves and brewed them as a bitter tea. Today it is sold as loose tea, powder and capsules.
It is marketed mainly for the prostate and the urinary tract. Sellers also push it for "cleansing the blood", for swelling and for infections.
Here is the honest verdict. There are no good human trials behind any of those claims. Long use in a tradition is not proof that a plant works, and it is not proof that it is safe.
Almost everything said about huamanpinta comes from test tubes and from rats and mice. Animal results often fail to repeat in people. Treat the selling points as untested.
The plant is not known to be poisonous. But "no reported harm" is not the same as "shown to be safe", because nobody has studied it in people with any care.
No one has shown how huamanpinta acts inside the human body.
In test tubes, extracts mop up free radicals. Those are unstable molecules that can damage cells. This is a common finding for any plant rich in flavonoids, and it does not tell you what a cup of tea does.
In rats given a drug that swells the prostate, one extract reduced the swelling and some signs of inflammation (swelling and irritation). That is animal work. It has not been repeated in people.
In mouse studies, extracts shifted some immune signals up or down. What that would mean for your immune system is unknown.
Lab work also suggests the plant slows some bacteria in a dish. Whether that happens anywhere in your body is not established.
So the prostate and urinary claims rest on tradition plus animal data. Read the mechanism as a hypothesis, not as a fact about you.
Most buyers meet it as a dried herb for tea or as capsules.
Common forms:
- Cut dried stems and leaves, brewed as a tea. - Milled powder, stirred into water or juice. - Capsules, usually a plain powder rather than an extract.
- Liquid tinctures, less common outside Peru. - Mixed Andean blends, often with chanca piedra, hercampuri or pasuchaca.
Blends are the weak point. You cannot tell how much huamanpinta is in them. Other herbs in the mix carry their own cautions.
One naming trap matters. Huamanpinta is not huamanripa, a different Andean cough plant from the Senecio group.
Some Senecio plants hold compounds that can damage the liver. Check the botanical name on the pack.
Huamanpinta has a real but regional place in Andean folk medicine.
The shrub grows on high Peruvian and Bolivian grassland, roughly 3,000 to 4,500 metres up. The name comes from Quechua. Village healers used the dried stems and leaves as a bitter brew.
Recorded folk uses centred on urine problems, the prostate, wounds and general "blood cleansing". It was also taken as a bitter tonic after illness.
It spread beyond the highlands late. Most commercial sales date from the past few decades, when Peruvian herbs found export and online markets.
This page describes those uses. It does not recommend them.
Stop and get medical help the same day if you have:
- Blood in your urine. - Fever, chills or back pain with urinary symptoms. - Pain or difficulty passing urine that is getting worse. - A rash, swollen lips or face, or any trouble breathing. - Yellow skin or eyes, or dark urine.
Go to an emergency department if you cannot pass urine at all. That is an emergency.
Book a routine appointment if urinary or prostate symptoms last more than two weeks, even if they are mild.
In Peru it is sold freely as a herbal product and is part of the local plant trade. In the United States it is a dietary supplement, so it is not reviewed or approved for treating any disease. In the UK and EU it is not an authorised herbal medicine, and products there are sold as food supplements.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.
